Es posible que algunas de las funciones que se muestran en el sitio web de EE. UU. no estén disponibles en su país.
The pandemic has forced the medical community to develop new imaging strategies that save time and avoid unnecessary staff exposures—and lung ultrasound has been crucial.¹
Lung ultrasound should not be solely or primarily relied upon for COVID-19 diagnosis or triage. In vitro diagnostic testing is currently the only definitive method to diagnose COVID-19.
1. https://doi.org/10.1002/emp2.12194
You may be 1 of 4600 rural healthcare clinics (RHCs) that qualify for federal government funds through December 31, 2021.
The American Rescue Plan supports the funding of tools and technologies that help mitigate the spread of COVID-19 within local communities.
Download free tools to kick-start your lung POCUS journey. Expedite COVID pneumonia detection at the bedside.
Aprenda la técnica básica sobre cómo evaluar la superficie del pulmón para localizar deslizamiento o artefactos con Butterfly iQ.
Comprehensive lung exams assisted by real-time segment-by-segment guidance have been built to help increase rapidity of frontline patient assessment, and potentially reduce viral exposure. Available to Pro and Enterprise members.
These videos are for informational purposes only, to demonstrate potential uses of the Butterfly devices. They are not a substitute for professional clinician training and experience. Clinicians are solely responsible for patient care and for exercising their independent clinical judgement at all times.
Literature suggests that patients with confirmed COVID-19 demonstrate typical lung imaging features, including: B lines, irregular pleural lines with sub-pleural consolidation and disease foci, predominantly in the lower posterior segments.
This and other videos are offered for demonstration only—always follow your institution’s protocols for proper use of PPE and cleaning and disinfection.
Evidence supporting the use of lung ultrasound in COVID-19 healthcare delivery.
Point-of-care lung ultrasound is more sensitive than CXR for evaluation of COVID-19.
Leer el artículoPOCUS can improve diagnostic sensitivity for COVID-19 pneumonia, in conjunction with PCR and clinical assessment.
Leer el artículoEvidence supporting the use of lung ultrasound in COVID-19 healthcare delivery.
The findings from this multi-center prospective report support the use of lung ultrasound in the follow-up of patients recovered from COVID-19, as a radiation-sparing, easy to use, novel care path.
Point-of-care lung ultrasound is more sensitive than CXR for evaluation of COVID-19.
Leer el artículoThis report details the integration of Lung Ultrasound into the home treatment plan of an HCP with COVID-19, using a novel Teleguidance approach
Leer el artículoPOCUS can improve diagnostic sensitivity for COVID-19 pneumonia, in conjunction with PCR and clinical assessment.
Leer el artículo
In 2020 we have learned that there are a number of possible situations where handheld whole-body ultrasound plays a valuable role. Bedside ultrasound has been shown to have a valuable cross-specialty role in informing decisions around COVID-19 across the full spectrum of clinical management.
POCUS is an initial imaging modality for patients presenting to the Emergency Department suspected of COVID-19 infection and pulmonary involvement. This reduces dependencies on CT and CXR, and can impact the ability to risk stratify while maintaining isolation protocols.
Handheld ultrasound setting can be utilized by HCPs in primary care, urgent care, skilled nursing, and home healthcare settings to help decrease the need for patient transport for advanced imaging.
With POCUS, the monitoring of hospitalized patients, particularly in high dependency units such as the ICU, can be done at the bedside. A dedicated handheld ultrasound system can remain with the patient throughout their hospital stay, eliminating the risk of patient-to-patient nosocomial transmission via ultrasound systems. Lung imaging findings have also been shown to support decisions about disease severity, and can help support critical care decisions such as ventilator allocation.
Systematic integration of portable ultrasound imaging in the community, leveraging telemedicine guidance when necessary, could facilitate early detection of imaging features typical of COVID-19. This has the potential to inform clinicians’ decisions around isolation and quarantine of early or asymptomatic cases. Telemedicine also has the ability to support remote clinician exams to keep healthy patients, such as those requiring routine prenatal monitoring, from entering a potentially infected facility or space. Read more here.
The Butterfly Education platform provides a diverse video library of instructional content to support our frontline COVID-19 care providers.
Learn how to perform and interpret lung ultrasound in COVID-19.
Aprenda la técnica básica sobre cómo evaluar la superficie del pulmón para localizar deslizamiento o artefactos con Butterfly iQ.
Comprehensive lung exams assisted by real-time segment-by-segment guidance has been built to help increase rapidity of frontline patient assessment, and potentially reduce viral exposure. Available to Pro and Enterprise members.
In December, Butterfly hosted a webinar with a panel of experts to discuss the role that lung ultrasound is playing in the fight against COVID-19.
Evidence, educational materials, clinical imagery and best practices, delivered directly to your inbox.
La ecografía pulmonar se utiliza para identificar complicaciones pulmonares en pacientes con casos sospechados o confirmados de COVID-19 y puede ayudar a estratificar el riesgo de los pacientes para su admisión y observación. No se puede utilizar para diagnosticar COVID-19. El diagnóstico definitivo se hace con la detección del virus SARS-CoV-2 (causante del COVID-19) mediante reacción en cadena de la polimerasa con transcriptasa inversa en tiempo real (rRT-PCR) en especímenes respiratorios.
Lung ultrasound is a portable, bedside, radiation-free, inexpensive imaging modality that can readily detect many features of COVID-19-associated lung disease. The cost, portability, accuracy, and ability to use in an isolated environment lead to significant potential benefit over chest radiography or computed tomography (CT) imaging. Imaging findings can accelerate disposition decisions while awaiting culture results.
El personal médico está utilizando la ecografía pulmonar para evaluar y monitorizar pacientes con hipoxemia y para evaluar a pacientes infectados de alto riesgo para estratificar las decisiones de diagnóstico. Los resultados de una ecografía pulmonar pueden ir cambiando de forma dinámica en el transcurso de una enfermedad, y vigilar la evolución de las líneas B y la consolidación (o la resolución con un regreso a una imagen con líneas A normal) puede aportar información de gran valor para el equipo médico. Aunque la TC tiene un valor demostrado en el diagnóstico de COVID-19, muchos pacientes están demasiado graves como para transportarlos o pueden aumentar el riesgo de exponer a más personal sanitario a la enfermedad. La TC también es más cara, y hay estudios que parecen indicar que la ecografía podría proporcionar la misma cantidad de información.
Se han descrito las siguientes características visibles en ecografía en pacientes con COVID-19:
· Línea pleural fragmentada e irregular
· Líneas B (focales, dispersas y confluentes)
· Afectación bilateral
· Afectación de segmentos posterior y lateral
· Consolidación pulmonar (desde pequeña hasta lobar, con o sin broncogramas aéreos)
· Derrames pleurales poco frecuentes
· Consulte este estudio y este estudio para más información
Varias exploraciones sucesivas con ecografía pulmonar pueden mostrar empeoramiento de líneas B y consolidaciones, que indican el avance de la enfermedad. Además, la vuelta a una imagen con líneas A normal puede indicar signos de recuperación. Se han descrito varios enfoques (protocolos de 6, 8, 12 y más de 14 zonas) de la evaluación de pulmones con ecografía. También puede servir para obtener imágenes del corazón como medida base de la fracción de expulsión. Esto podría ser especialmente relevante en cuidados intensivos, en pacientes en estado grave por el COVID-19.
We’ve expanded our list of chemically compatible cleaners and disinfectants for the iQ with 63 additional products. Clinicians may consider the use of a sterile probe sheath as an additional barrier precaution. View a demonstration video at the link: Compatible cleaners and disinfectants for COVID-19
Many users have reported positive results placing both Butterfly and mobile device in a standard probe sheath. CIVCO has created a unique landing page for sheaths that will work with the iQ. You may also use standard sheaths available from ProTek, Medline, Sheathes and other retailers. For more details, view our COVID-19 cleaning and disinfection page.
Estamos intentando activamente conectar con la comunidad médica y añadir a los datos disponibles para la investigación, la formación y la comprensión del COVID-19. Animamos al personal cualificado a que contribuya a nuestra biblioteca de casos positivos sin identificación, además de a compartir protocolos de atención médica. Póngase en contacto con nosotros en covid@butterflynetwork.com para más información.
The images and clips in our COVID-19 gallery originate from clinicians across the world and have been useful to accelerate learning and collaboration throughout our community. Please reach out to us via email at covid@butterflynetwork.com, and we will be happy to provide further instructions. We appreciate your contributions to this evolving resource center.